STOIC trial now published @LancetRespirMed. So excited to share the findings of our trial of inhaled budesonide for early #COVID19 A (long) thread 🧵 thelancet.com/journals/lanre…
We looked at 800 mcg of inhaled budesonide twice a day within 7 days of COVID19 symptom onset.
Primary outcome was requirement for urgent medical care. We also looked at temperature and oxygen saturation at home.